Interleukin-2 and C-reactive protein in assessing the effectiveness of pulmonary sarcoidosis treatment

Conclusions: Identifying patterns of these disorders at the molecular level intercellular interaction in pulmonary sarcoidosis enables to determine the effectiveness and adequacy of prescribed therapy, by patient-specific assessment of the inflammatory process activity.

Source: European Respiratory Journal - December 6, 2017 Category: Respiratory Medicine Authors: Ostrovskyy, M., Shvets, K., Ostrovska, K., Savelikhina, I., Kulynych-Miskiv, M., Varunkiv, O. Tags: Diffuse Parenchymal Lung Disease Source Type: research